» Articles » PMID: 26224101

Mechanisms Through Which a Small Protein and Lipid Preload Improves Glucose Tolerance

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2015 Jul 31
PMID 26224101
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Small protein or lipid preloads are able to improve glucose tolerance to a different extent and through different and poorly defined mechanisms. We aimed at quantifying the effect of a mixed protein and lipid preload and at evaluating the underlying mechanisms.

Methods: Volunteers with normal (NGT, n = 12) or impaired (IGT, n = 13) glucose tolerance and patients with type 2 diabetes (n = 10) underwent two OGTTs coupled to the double glucose tracer protocol, preceded by either 50 g of parmesan cheese, a boiled egg and 300 ml of water, or 500 ml of water. We measured plasma glucose, insulin, C-peptide, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), pancreatic polypeptide (PP), NEFA and glucose tracers, and calculated glucose fluxes, beta cell function variables, insulin sensitivity and clearance.

Results: After the nutrient preload, the OGTT-induced rise of plasma glucose was lower than after water alone in each study group. This reduction—more pronounced across classes of glucose tolerance (NGT -32%, IGT -37%, type 2 diabetes -49%; p < 0.002)—was the result of different combinations of slower exogenous glucose rate of appearance, improved beta cell function and reduced insulin clearance, in this order of relevance, which were associated with an only mild stimulation of GIP and GLP-1.

Conclusions/interpretation: After a non-glucidic nutrient preload, glucose tolerance improved in proportion to the degree of its baseline deterioration through mechanisms that appear particularly effective in type 2 diabetes. Exploiting the physiological responses to nutrient ingestion might reveal, at least in the first stages of the diabetic disease, a potent tool to improve daily life glycaemic control.

Trial Registration: ClinicalTrials.gov NCT02342834 FUNDING: This work was supported by grants from the University of Pisa (Fondi di Ateneo) and by FCT grant (PIC/IC/82956/2007).

Citing Articles

Sequence of Eating at Japanese-Style Set Meals Improves Postprandial Glycemic Elevation in Healthy People.

Kurotobi Y, Kuwata H, Matsushiro M, Omori Y, Imura M, Nakatani S Nutrients. 2025; 17(4).

PMID: 40004986 PMC: 11858527. DOI: 10.3390/nu17040658.


Insights in Nutrition to Optimize Type 1 Diabetes Therapy.

Cadario F Nutrients. 2024; 16(21).

PMID: 39519472 PMC: 11547730. DOI: 10.3390/nu16213639.


Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners.

Shibib L, Al-Qaisi M, Guess N, Miras A, Greenwald S, Pelling M Diabetes Metab Syndr Obes. 2024; 17:3111-3130.

PMID: 39206417 PMC: 11350065. DOI: 10.2147/DMSO.S458894.


Timing and Nutrient Type of Isocaloric Snacks Impacted Postprandial Glycemic and Insulinemic Responses of the Subsequent Meal in Healthy Subjects.

Lou X, Fan Z, Wei J, Peng X, Hu J, Lu X Nutrients. 2024; 16(4).

PMID: 38398859 PMC: 10891798. DOI: 10.3390/nu16040535.


Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial.

Trico D, Masoni M, Baldi S, Cimbalo N, Sacchetta L, Scozzaro M Diabetologia. 2023; 67(2):263-274.

PMID: 37971503 PMC: 10789836. DOI: 10.1007/s00125-023-06045-9.


References
1.
Nauck M, Baller B, Meier J . Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes. 2004; 53 Suppl 3:S190-6. DOI: 10.2337/diabetes.53.suppl_3.s190. View

2.
Lan-Pidhainy X, Wolever T . The hypoglycemic effect of fat and protein is not attenuated by insulin resistance. Am J Clin Nutr. 2009; 91(1):98-105. DOI: 10.3945/ajcn.2009.28125. View

3.
Collier G, ODea K . The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr. 1983; 37(6):941-4. DOI: 10.1093/ajcn/37.6.941. View

4.
Meier J, Gallwitz B, Salmen S, Goetze O, Holst J, Schmidt W . Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab. 2003; 88(6):2719-25. DOI: 10.1210/jc.2003-030049. View

5.
Bonuccelli S, Muscelli E, Gastaldelli A, Barsotti E, Astiarraga B, Holst J . Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms. Am J Physiol Endocrinol Metab. 2009; 297(2):E532-7. DOI: 10.1152/ajpendo.00127.2009. View